Stay updated on Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedUpdated the Publications section description to say PubMed-listed publications are automatically populated for the study and may not all pertain to it. Updated the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page no longer displays the funding-status banner; this change does not affect core study details, eligibility, or results on the ClinicalTrials.gov page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.2%

- Check71 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference1%

- Check78 days agoChange DetectedMetadata update: added a new contact-style entry and version v3.1.0, and removed the previous version v3.0.2.SummaryDifference0.0%

- Check92 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' element was removed, with no other substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.